Dr Andrew D. Bretherick

Senior Clinical Research Fellow


Dr Andrew Bretherick is a Quantitative Geneticist in the MRC Human Genetics Unit and Consultant in Anaesthetics (Pain Medicine) for NHS Tayside. He has extensive expertise in drug-target discovery using genetics and molecular traits, having previously worked to identify factors underlying host susceptibility to Covid-19.

He graduated from the University of Edinburgh in Medical Sciences (with first class honours in Molecular Biology) in 2006, and Medicine in 2009. Following an academic foundation post in the south-east of Scotland, he worked in Queensland, Australia in 2011/2012, before returning to undertake clinical training in Anaesthetics. He was appointed to the prestigious Wellcome funded Edinburgh Clinical Academic Track (ECAT) scheme in 2015, completing a PhD in Quantitative Genetics in 2020, and clinical training in Anaesthetics in 2023. He is a fellow of the Royal College of Anaesthetists (FRCA), and a fellow of the faculty of Pain Medicine of the Royal College of Anaesthetists (FFPMRCA).  

Research summary

Drug-target Discovery; Instrumental Variable Analysis; Quantitative Genetics; Fibromyalgia; Proteomics; Machine Learning.

View all 22 publications on Research Explorer